Generic partners India pharma
Wednesday, 27 August, 2008
Biotech Capital [ASX: BTC] investee Generic Health has secured a strategic partnership with one of India's five largest pharmaceutical companies.
Under the arrangement the Indian pharmaceutical company Lupin will become a significant shareholder in Generic Health, obtaining board representation in exchange for a large cash investment.
Lupin will also provide Generic Health with access to 16 dossiers of generic drugs, including 14 already approved by the necessary regulatory bodies, as an in-kind value offer.
Generic Health announced a partnership with Actavis in June this year, and acquired Bellwether Pharma in 2007.
Defective sperm doubles pre-eclampsia risk in IVF patients
A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...
Free meningococcal B vaccines coming to the NT
The Northern Territory Government has confirmed the rollout of a free meningococcal B vaccine...
Mouth bacteria linked to increased head and neck cancer risk
More than a dozen bacterial species that live in people's mouths have been linked to a...
